Koroleva I.S., Koroleva M.A., Churilova N.S., Gritsai M.I., Beloshitsky G.V.
Meningococcal infection in modern realities: a narrative review
|
№2 / 2023
|
Koroleva M.A., Gritsay M.I., Koroleva I.S., Melnikova A.A.
Meningococcal infection in the Russian Federation: a ten-year follow-up
|
№2 / 2022
|
Koroleva M.A., Gritsay M.I., Mironov K.O., Yarygina E.A., Valdokhina A.V., Yanushevich Yu.V., Mikhailova Yu.V., Speranskaya A.S., Melnikova А.А., Koroleva I.S.
Epidemiological manifestations of the outbreak of meningococcal infection caused by Neisseria meningitidis serogroup A in Novosibirsk in 2019
|
№2 / 2021
|
Gilmullina F.S., Zagidullina A.I., Rodygina Zh.A.
Able-bodied population’s attitude towards influenza vaccination
|
№4 / 2019
|
Provorova V.V., Krasnova E.I., Khokhlova N.I., Kuimova I.V., Izvekova I.Ya.
Influenza in the HIV infected
|
№2 / 2019
|
Zaitsev A.A., Akimkin V.G.
Acute bronchitis: topical issues of epidemiology, etiology, pharmacotherapy and prevention
|
№2 / 2019
|
Nozdracheva A.V., Semenenko T.A., Rusakova E.V., Guseva E.V., Ivanova M.Yu., Gotvyanskaya T.P.
Herd immunity to measles, rubella, and mumps viruses in the population of Moscow in 2016–2017
|
№2 / 2019
|
Ponezheva Zh.B., Arakelyan A.K., Kozlova M.S., Vdovina E.T.
Measles in adults
|
№2 / 2018
|
Koroleva I.S., Koroleva M.A., Melnikova A.A.
Epidemiology of purulent bacterial meningitis in the period of pneumococcal and haemophilus vaccination in the Russian Federation
|
№6 / 2017
|
Druzhinina T.A., Shoshin A.A., Cheprasova E.V., Popova O.V.
Epidemiology of pertussis in the Yaroslavl Region during planned mass immunization
|
№2 / 2017
|
Selkova E.P., Aleshkin V.A., Grenkova T.A., Katlinsky A.V., Polezhaeva N.A., Suranova T.G., Lapickaya A.S.
The results of influenza immunoprophylaxis in the 2015–2016 epidemic season
|
№1 / 2017
|
Selkova E.P., Grenkova T.A., Aleshkin V.А., Gudova N.V., . Lytkina I.N., Mikhailova E.V., Yashina A.Ya., Fedyakina I.T.
Investigation of the immunogenicity, efficacy, and tolerability of the Russian vaccine Ultrix® among people at high risk for the infection and morbidity of influenza and acute respiratory viral infections
|
№1 / 2016
|